Activation of tumor cell integrin αvβ3 by radiation and reversal of activation by chemically modified tetraiodothyroacetic acid (tetrac)

References

• Alberti C. Prostate cancer: radioresistance molecular target-related markers and foreseeable modalities of radiosensitization. Eur Rev Med Pharmacol Sci. 2014;18(16):2275–2282.
   PubMed Web of Science ®Google Scholar
• Chang L, Graham PH, Hao J, et al. Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy. Cancer Metastasis Rev. 2014;33(2–3):469–496. doi:10.1007/s10555-014-9493-5.
   PubMed Web of Science ®Google Scholar
• Spratt DE, Evans MJ, Davis BJ, et al. Androgen receptor upregulation mediates radioresistance after ionizing radiation. Cancer Res. 2015;75(22):4688–4696. doi:10.1158/0008-5472.CAN-15-0892.
   PubMed Web of Science ®Google Scholar
• Korpela E, Vesprini D, Liu SK. MicroRNA in radiotherapy: miRage or miRador? Br J Cancer. 2015;112(5):777–782.
   PubMed Web of Science ®Google Scholar
• Davis PJ, Goglia F, Leonard JL. Nongenomic actions of thyroid hormone. Nat Rev Endocrinol. 2016;12(2):111–121.
   PubMed Web of Science ®Google Scholar
• Ni J, Cozzi PJ, Hao JL, et al. CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance. Prostate. 2014;74(6):602–617. doi:10.1002/pros.22775.
   PubMed Web of Science ®Google Scholar
• Skvortsova I, Skvortsov S, Stasyk T, et al. Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells. Proteomics. 2008;8(21):4521–4533. doi:10.1002/pmic.200800113.
   PubMed Web of Science ®Google Scholar
• Chang L, Graham PH, Ni J, et al. Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance. Crit Rev Oncol Hematol. 2015;96(3):507–517. doi:10.1016/j.critrevonc.2015.07.005.
   PubMed Web of Science ®Google Scholar
• Shang Z-F, Wei Q, Yu L, et al. Suppression of PC-1/PrLZ sensitizes prostate cancer cells to ionizing radiation by attenuating DNA damage repair and inducing autophagic cell death. Oncotarget. 2016;7(38):62340–62351. doi:10.18632/oncotarget.v7i38.
   PubMedGoogle Scholar
• Sun SQ, Gu X, Gao XS, et al. Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation. Oncotarget. 2016;7(30):48050–48058. doi:10.18632/oncotarget.10347.
   PubMedGoogle Scholar
• Yang C, He H, Zhang T, Chen Y, Kong Z. Decreased DAB2IP gene expression, which could be induced by fractionated irradiation, is associated with resistance to γ-rays and α-particles in prostate cancer cells. Mol Med Rep. 2016;14(1):567–573.
   PubMed Web of Science ®Google Scholar
• Monferran S, Skuli N, Delmas C, et al. αvβ3 and αvβ5 integrins control glioma cell response to ionising radiation through ILK and RhoB. Int J Cancer. 2008;123(2):357–364. doi:10.1002/ijc.23498.
   PubMed Web of Science ®Google Scholar
• Weissmann R, Kacprowski T, Peper M, et al. Transcriptome alterations in x-irradiated human gingiva fibroblasts. Health Phys. 2016;111(2):75–84. doi:10.1097/HP.0000000000000419.
   PubMed Web of Science ®Google Scholar
• Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010;10(1):9–22.
   PubMed Web of Science ®Google Scholar
• Broustas CG, Lieberman HB. RAD9 enhances radioresistance of human prostate cancer cells through regulation of ITGB1 protein levels. Prostate. 2014;74(14):1359–1370.
   PubMed Web of Science ®Google Scholar
• Davis PJ, Glinsky GV, Lin H-Y, et al. Cancer cell gene expression modulated from plasma membrane integrin αvβ3 by thyroid hormone and nanoparticulate tetrac. Front Endocrinol (Lausanne). 2014;5:240.
   PubMed Web of Science ®Google Scholar
• Hercbergs AH, Lin HY, Davis FB, Davis PJ, Leith JT. Radiosensitization and production of DNA double-strand breaks in U87MG brain tumor cells induced by tetraiodothyroacetic acid (tetrac). Cell Cycle. 2011;10(2):352–357.
   PubMed Web of Science ®Google Scholar
• Byron A, Humphries JD, Askari JA, Craig SE, Mould AP, Humphries MJ. Anti-integrin monoclonal antibodies. J Cell Sci. 2009;122(Pt 22):4009–4011.
   PubMed Web of Science ®Google Scholar
• Li M, Pathak RR, Lopez-Rivera E, Friedman SL, Aguirre-Ghiso JA, Sikora AG. The in ovo chick chorioallantoic membrane (CAM) assay as an efficient xenograft model of hepatocellular carcinoma. J Vis Exp. 2015;2015(104):52411. JoVE
   Google Scholar
• Bergh JJ, Lin HY, Lansing L, et al. Integrin αVβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology. 2005;146(7):2864–2871. doi:10.1210/en.2005-0102.
   PubMed Web of Science ®Google Scholar
• Felding-Habermann B, O’Toole TE, Smith JW, et al. Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci U S A. 2001;98(4):1853–1858. doi:10.1073/pnas.98.4.1853.
   PubMed Web of Science ®Google Scholar
• Pond-Tor S, Rhodes RG, Dahlberg PE, Leith JT, McMichael J, Dahlberg AE. Enhancement of radiosensitivity of the MCF-7 breast cancer cell line with human chorionic gonadotropin. Breast Cancer Res Treat. 2002;72(1):45–51.
   PubMed Web of Science ®Google Scholar
• Davis PJ, Davis FB, Mousa SA, Luidens MK, Lin H-Y. Membrane receptor for thyroid hormone: physiologic and pharmacologic implications. Annu Rev Pharmacol Toxicol. 2011;51:99–115.
   PubMed Web of Science ®Google Scholar
• Alghisi GC, Ponsonnet L, Ruegg C. The integrin antagonist cilengitide activates αvβ3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells. PLoS One. 2009;4(2):e4449.
   PubMed Web of Science ®Google Scholar
• Radmaneshfar E, Kaloriti D, Gustin MC, et al. From start to finish: the influence of osmotic stress on the cell cycle. PLoS One. 2013;8(7):e68067. doi:10.1371/journal.pone.0068067.
   PubMed Web of Science ®Google Scholar
• Schliess F, Haussinger D. Osmosensing by integrins in rat liver. Methods Enzymol. 2007;428:129–144.
   PubMed Web of Science ®Google Scholar
• Onodera Y, Nam J-M, Sabe H. Intracellular trafficking of integrins in cancer cells. Pharmacol Ther. 2013;140(1):1–9.
   PubMed Web of Science ®Google Scholar
• Kamata T, Handa M, Takakuwa S, et al. Epitope mapping for monoclonal antibody reveals the activation mechanism for αVβ3 integrin. PLoS One. 2013;8(6):e66096. doi:10.1371/journal.pone.0066096.
   PubMed Web of Science ®Google Scholar